Ng’andwe C, Lowe JJ, Richards PJ, Hause L, Wood C, Angeletti PC. The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa. BMC Infect Dis. 2007;7:77. doi:10.1186/1471-2334-7-77.
Article
PubMed
PubMed Central
Google Scholar
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman, Galichet L, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens—Part B: biological agents. Lancet Oncol. 2009;10:321–2.
Article
Google Scholar
Hawes SE, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis. 2003;188(4):555–63.
Article
Google Scholar
De Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papilloman DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453–9.
Article
Google Scholar
Russomano F, Paz BR, Camargo MJ, Grinstejn BG, Friedman RK, Tristao MA, Oliveira CA. Recurrence of cervical intraepithelial neoplasia in human immunodeficiency virus-infected women treated by means of electrosurgical excision of the transformation zone (LLETZ) in Rio de Janeiro, Brazil. Sao Paulo Med J. 2013;131(6):405–10. doi:10.1590/1516-3180.2013.1316578.
Article
PubMed
Google Scholar
Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer: burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;31:3–13.
Article
Google Scholar
Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128(4):927–35.
Article
CAS
Google Scholar
Rahman M, Sasagawa T, Yamada R, Kingoro A, Ichimura H, Makinoda S. High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of kenyan women infected with human immunodeficiency virus. J Med Virol. 2011;83:1988–96.
Article
Google Scholar
Didelot-Rousseau MN, Nagot N, Costes-Martineau V, Valles X, Ouedraogo A, Konate I, Weiss HA, Van de Perre P, Mayaud P, Segondy M, Yerelon Study Group. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer. 2006;95:355–62.
Article
CAS
Google Scholar
Ahdieh L, Klein RS, Burk R, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in Human Immunodeficiency Virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001;184:682–90.
Article
CAS
Google Scholar
Levi JE, Kleter B, Quint WG, Fink MC, Canto CL, Matsubara R, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol. 2002;40:3341–5.
Article
Google Scholar
Moscicki AB, Ellenberg JH, Farhat S, Xu J. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis. 2004;190:37–45.
Article
Google Scholar
Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, Hall C, Bacon M, Levine AM, Watts DH, Silverberg MJ, Xue X, Schlecht NF, Melnick S, Palefsky JM. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97:577–86.
Article
Google Scholar
Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999;91:226–36.
Article
CAS
Google Scholar
Schopp B, Holz B, Zago M, Stubenrauch F, Petry KU, Kjaer SK, et al. Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 test. J Med Virol. 2010;82:605–15.
Article
Google Scholar
Barcellos RB, Almeida SE, Sperhacke RD, Verza M, Rosso F, Medeiros RM, et al. Evaluation of a novel microplate colorimetric hybridization genotyping assay for human papillomavirus. J Virol Methods. 2011;77:38–43.
Article
Google Scholar
Friedman AL, Oruko KO, et al. Preparing for human papillomavirus vaccine introduction in Kenya: implications from focus-group and interview discussions with caregivers and opinion leaders in Western Kenya. BMC Public Health. 2014;14:855.
Article
Google Scholar
International Models project on women’s right. Current Legal Framework: Prostitution in Kenya. 2011. http://www.impowr.org/content/current-legal-framework-prostitution-kenya. Accessed 8 May 2016.
Finan RR, Tamim H, Almawi WY. Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology. Arch Gynecol Obstet. 2002;266(3):168–71.
Article
CAS
Google Scholar
Syrjanen K, Mantyjarvi R, Vayrynen M, et al. Chlamydial cervicitis in women followed-up for human papillomavirus (HPV) lesions of the uterine cervix. Acta Obstet Gynecol Scand. 1985;64:467–71.
Article
CAS
Google Scholar
Platz-Christensen JJ, Sundstrom E, Larsson PG. Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand. 1994;73:586–8.
Article
CAS
Google Scholar
Noel JC, Fayt I, Romero Munoz MR, et al. High prevalence of high-risk human papillomavirus infection among women with Trichomonas vaginalis infection on monolayer cytology. Arch Gynecol Obstet. 2010;282:503–5.
Article
Google Scholar
Ngugi EN, Plummer FA, Simonsen JA, Cameron DW, Bosire M, et al. Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet. 1988;2(8616):887–90. doi:10.1016/s0140-6736(88)92480-4.
Article
CAS
PubMed
Google Scholar
Odek WO, Githuka GN, Avery L, Njoroge PK, Kasonde L, Gorgens M, et al. Estimating the size of the female sex worker population in Kenya to inform HIV prevention programming. PLoS One. 2014;9(3):e89180. doi:10.1371/journal.pone.0089180.
Article
CAS
PubMed
PubMed Central
Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, the STROBE initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7.
Article
Google Scholar
Ulin PR, Robinson ET, Tolley EE. Qualitative methods in public health: A field guide for applied research. San Francisco: APA (6th ed.) Jossey-Bass; 2005.
Musa J, Achenbach C, Taiwo B, et al. High-risk human papilloma virus and cervical abnormalities in HIV-infected women with normal cervical cytology. Infect Agents Cancer. 2014;9:36.
Article
Google Scholar
Davey DD. Cervical cytology classification and the Bethesda System. Cancer J. 2003;9(5):327–34.
Article
Google Scholar
Grinsztejn B, Veloso VG, Levi JE, Velasque L, Luz PM, et al. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-1-infected Brazilian women. Int J Infect Dis. 2008;13(1):72–80.
Article
Google Scholar
Temmerman M, Tyndall MW, Kidula N, Claeys P, Muchiri L, et al. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection. Int J Gynaecol Obstet. 1999;65(2):171–81.
Article
CAS
Google Scholar
Yap EH, Ho TH, Chan YC, et al. Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients. Genitourin Med. 1995;71:402–4.
CAS
PubMed
PubMed Central
Google Scholar
Donders GGG, Depuydt CE, Bogers J-P, Vereecken AJ. Association of Trichomonas vaginalis and Cytological Abnormalities of the Cervix in Low Risk Women. Kaul R, ed. PLoS ONE. 2013;8(12):e86266. doi:10.1371/journal.pone.0086266.
Viikki M, Pukkala E, Nieminen P, Hakama M. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol. 2000;39:71–5.
Article
CAS
Google Scholar
Menon S, Rossi R, Benoy I, Bogers JP, van den Broeck D. Human papilloma virus infection in HIV-infected women in Belgium: implications for prophylactic vaccines within this subpopulation. Eur J Cancer Prev. 2016. [Epub ahead of print].
Malagón T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(10):781–9. doi:10.1016/S1473-3099(12)70187-1.
Article
CAS
PubMed
Google Scholar
Padalko E, Ali-Risasi C, Van Renterghem L, Bamelis M, De Mey A, Sturtewagen Y, Vastenavond H, Vanden Broeck D, Weyers S, Praet M. Evaluation of the clinical significance of human papillomavirus (HPV) 53. Eur J Obstet Gynecol Reprod Biol. 2015;191:7–9. doi:10.1016/j.ejogrb.2015.04.004.
Article
PubMed
Google Scholar